Concepedia

Lawrence J. Thomas

LJ

Statistics

Publications

46

Citations

2.5K

H-Index

29

Active since

1952

Affiliations

Celldex Therapeutics (United States)(Current)

Massachusetts General Hospital

Oncotherapeutics (United States)

Harvard University Press

University of Massachusetts Chan Medical School

Lawrence J. Thomas is an author at Celldex Therapeutics (United States) specializing in immunology, life sciences, and oncology.

ORCID

Publications per year

1952–2022

46

Publications

46

Vaccine-Induced Antibodies Inhibit CETP Activity In Vivo and Reduce Aortic Lesions in a Rabbit Model of Atherosclerosis

Charles W. Rittershaus, David P. Miller, Lawrence J. Thomas et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2000 · 312 citations

, , +16

M. tuberculosis-Initiated Human Mannose Receptor Signaling Regulates Macrophage Recognition and Vesicle Trafficking by FcRγ-Chain, Grb2, and SHP-1

Murugesan V. S. Rajaram, Eusondia Arnett, Abul Azad et al. · Cell Reports · 2017 · 142 citations · Full text

, , +11

Identification of defects in glycosylphosphatidylinositol anchor biosynthesis in the Thy-1 expression mutants

Eiji Sugiyama, R DeGasperi, Masaharu Urakaze et al. · Journal of Biological Chemistry · 1991 · 139 citations · Full text

, , +17

Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria

Dorothea Terhorst‐Molawi, Tomasz Hawro, Eva Grekowitz et al. · Allergy · 2022 · 121 citations · Full text

, , +17

PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell–Driven Antitumor Immunity

Sarah L. Buchan, Mohannad Fallatah, Stephen M. Thirdborough et al. · Clinical Cancer Research · 2018 · 112 citations · Full text

, , +17

1–5 of 46